Mentor Areas
Under Dr. Vanderver’s leadership, the multidisciplinary Leukodystrophy Center team is focused on creating new standards of care for children with leukodystrophies by advancing leukodystrophy gene discovery, creating new therapies, and supporting and advocating for patients and their families. In parallel with this strong clinical program, Dr. Vanderver’s preclinical and clinical research projects will aim to discover molecular therapeutics that target the genetics of leukodystrophy subtypes. Our bench research team has validated preclinical use of lentiviral gene therapy in Metachromatic Leukodystrophy and ASOs in H-ABC, as well as novel pharmacoresponsive biomarkers. Our clinical research team supports industry and investigator-initiated clinical trials, as well as improving cutting edge diagnostic approaches. In addition to her clinical and research efforts, Dr. Vanderver leads the Global Leukodystrophy Initiative. This multisite research consortium includes parents, clinicians, and researchers, to improve clinical trial readiness through regulatory-ready natural history studies. Together, these efforts aim to improve diagnosis, care and therapies for patients living with leukodystrophy.
Description:
Projects will vary. Interested students should contact us to discuss possibilities.
Preferred Qualifications
No specific qualifications.
Details:
Preferred Student Year
First-year, Second-Year, Junior, Senior
Academic Term
Fall, Spring, Summer
I prefer to have students start during the above term(s).Volunteer
Yes
Yes indicates that faculty are open to volunteers.Paid
Yes
Yes indicates that faculty are open to paying students they engage in their research, regardless of their work-study eligibility.Work Study
Yes
Yes indicates that faculty are open to hiring work-study-eligible students.